Neurodevelopmental outcome of fetuses with increased nuchal translucency and apparently normal prenatal and/or postnatal assessment: A systematic review

Ultrasound in Obstetrics and Gynecology

Volumn 39, Issue 1, 2012, Pages 10-19

  Sotiriadis, A ^a   Papatheodorou, S ^b   Makrydimas, G ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

neurodevelopment; nuchal translucency; ultrasound

Indexed keywords

DEVELOPMENTAL DISORDER; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INFANT; MALE; NEWBORN; NUCHAL TRANSLUCENCY MEASUREMENT; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY OUTCOME; PRESCHOOL CHILD; PROGNOSIS; PSYCHOMOTOR PERFORMANCE; REVIEW; RISK FACTOR;

CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PROGNOSIS; PSYCHOMOTOR PERFORMANCE; RISK FACTORS;

EID: 84555189415     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.10143     Document Type: Review

References (33)

1. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH,. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 2001; 18: 9-17.
2. Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH,. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1998; 11: 391-400. (Pubitemid 28344740)
3. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB,. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012. (Pubitemid 30214957)
4. Whittemore R, Knafl K,. The integrative review: updated methodology. J Adv Nurs 2005; 52: 546-553. (Pubitemid 41686698)
5. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2010; http://www.ohri.ca/programs/ clinicalepi?demiology/oxford.htm
6. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560. (Pubitemid 37088507)
7. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A,. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006; 6: 31.
8. Mula R, Goncé A, Bennásar M, Arigita M, Meler E, Nadal A, Sánchez A, Botet F, Borrell A,. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcome at 2 years of age. Ultrasound Obstet Gynecol 2012; 39: 34-41.
9. Cheng CC, Bahado-Singh RO, Chen SC, Tsai MS,. Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening. Int J Gynaecol Obstet 2004; 84: 5-9. (Pubitemid 38064136)
10. Schou KV, Kirchhoff M, Nygaard U, Jorgensen C, Sundberg K,. Increased nuchal translucency with normal karyotype: a follow-up study of 100 cases supplemented with CGH and MLPA analyses. Ultrasound Obstet Gynecol 2009; 34: 618-622.
11. Baumann C, Delagarde R, Vuillard E, Oury JF,. [Long-term follow-up of children with increased nuchal translucency and normal karyotype]. J Gynecol Obstet Biol Reprod (Paris) 2005; 34: S97-S102.
12. Adekunle O, Gopee A, el-Sayed M, Thilaganathan B,. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population. Br J Radiol 1999; 72: 457-460. (Pubitemid 29241582)
13. Senat MV, De Keersmaecker B, Audibert F, Montcharmont G, Frydman R, Ville Y,. Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype. Prenat Diagn 2002; 22: 345-349. (Pubitemid 34538557)
14. Hiippala A, Eronen M, Taipale P, Salonen R, Hiilesmaa V,. Fetal nuchal translucency and normal chromosomes: a long-term follow-up study. Ultrasound Obstet Gynecol 2001; 18: 18-22.
15. Van Vugt JM, Tinnemans BW, Van Zalen-Sprock RM,. Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks' gestation. Ultrasound Obstet Gynecol 1998; 11: 407-409. (Pubitemid 28344742)
16. Cha'ban FK, Van Splunder P, Los FJ, Wladimiroff JW,. Fetal outcome in nuchal translucency with emphasis on normal fetal karyotype. Prenat Diagn 1996; 16: 537-541. (Pubitemid 26187704)
17. Bilardo CM, Muller MA, Pajkrt E, Clur SA, van Zalen MM, Bijlsma EK,. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound Obstet Gynecol 2007; 30: 11-18. (Pubitemid 47074846)
18. Maymon R, Jauniaux E, Cohen O, Dreazen E, Weinraub Z, Herman A,. Pregnancy outcome and infant follow-up of fetuses with abnormally increased first trimester nuchal translucency. Hum Reprod 2000; 15: 2023-2027.
19. Axt-Fliedner R, Hartge D, Chiriac A, Krapp M, Berg C, Geipel A, Germer U, Gembruch U,. Long-term outcome for children born after a first-trimester measurement of increased nuchal translucency with a normal karyotype: a retrospective analysis. Ultraschall Med 2009; 30: 558-563.
20. Brady AF, Pandya PP, Yuksel B, Greenough A, Patton MA, Nicolaides KH,. Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation. J Med Genet 1998; 35: 222-224. (Pubitemid 28159927)
21. Jenewein N, Scheier M, Kiechl-Kohlendorfer U,. [Long term follow-up of children with increased nuchal translucency and normal karyotype on first trimester sonography]. Klin Padiatr 2009; 221: 14-18.
22. th percentile or greater with normal karyotype: a prospective study. Am J Obstet Gynecol 2007; 196: 53.e1-6.
23. Miltoft CB, Ekelund CK, Hansen BM, Lando A, Petersen OB, Skovbo P, Jørgensen FS, Sperling L, Zingenberg H, Nikkilä A, Shalmi AC, Stornes I, Ersbak V, Tabor A,. Increased nuchal translucency, normal karyotype and infant development. Ultrasound Obstet Gynecol 2012; 39: 28-33.
24. Simpson GA, Colpe L, Greenspan S,. Measuring functional developmental delay in infants and young children: prevalence rates from the NHIS-D. Paediatr Perinat Epidemiol 2003; 17: 68-80. (Pubitemid 37128711)
25. Stevenson J, Richman N,. The prevalence of language delay in a population of three-year-old children and its association with general retardation. Dev Med Child Neurol 1976; 18: 431-441.
26. Blanchard LT, Gurka MJ, Blackman JA,. Emotional, developmental, and behavioral health of American children and their families: a report from the 2003 National Survey of Children's Health. Pediatrics 2006; 117: e1202-e1212. (Pubitemid 46071219)
27. Nicolaides KH,. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004; 191: 45-67. (Pubitemid 39077955)
28. Ozmen M, Tatli B, Aydinli N, Caliskan M, Demirkol M, Kayserili H,. Etiologic evaluation in 247 children with global developmental delay at Istanbul, Turkey. J Trop Pediatr 2005; 51: 310-313. (Pubitemid 41487869)
29. Shevell MI, Majnemer A, Rosenbaum P, Abrahamowicz M,. Etiologic determination of childhood developmental delay. Brain Dev 2001; 23: 228-235. (Pubitemid 32455527)
30. Council on Children With Disabilities; Section on Developmental Behavioral Pediatrics; Bright Futures Steering Committee; Medical Home Initiatives for Children With Special Needs Project Advisory Committee. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Pediatrics 2006; 118: 405-420.
31. Petersen MC, Kube DA, Palmer FB,. Classification of developmental delays. Semin Pediatr Neurol 1998; 5: 2-14. (Pubitemid 28146583)
32. Limbos MM, Joyce DP,. Comparison of the ASQ and PEDS in screening for developmental delay in children presenting for primary care. J Dev Behav Pediatr 2011; 32: 499-511.
33. Aylward GP, Verhulst SJ,. Predictive utility of the Bayley Infant Neurodevelopmental Screener (BINS) risk status classifications: clinical interpretation and application. Dev Med Child Neurol 2000; 42: 25-31. (Pubitemid 30009138)